Defence Therapeutics Inc. (DTCFF)
USD 0.64
(-35.3%)
USD 0.64
(-35.3%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.68 Million CAD | 261.43% |
| 2023 | -1.04 Million CAD | -106.61% |
| 2022 | -506.69 Thousand CAD | 90.71% |
| 2021 | -5.45 Million CAD | -192.24% |
| 2020 | -1.86 Million CAD | -243493.6% |
| 2019 | -766.00 CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 1.68 Million CAD | 55.47% |
| 2024 Q2 | 1.16 Million CAD | 304.23% |
| 2024 Q1 | 287.8 Thousand CAD | 127.49% |
| 2024 Q3 | 1.08 Million CAD | -6.57% |
| 2023 Q1 | -130.83 Thousand CAD | 74.18% |
| 2023 FY | -1.04 Million CAD | -106.61% |
| 2023 Q4 | -1.04 Million CAD | 15.24% |
| 2023 Q3 | -1.23 Million CAD | -179.18% |
| 2023 Q2 | 1.55 Million CAD | 1292.22% |
| 2022 Q4 | -506.69 Thousand CAD | 68.12% |
| 2022 FY | -506.69 Thousand CAD | 90.71% |
| 2022 Q3 | -1.58 Million CAD | 44.19% |
| 2022 Q2 | -2.84 Million CAD | 36.86% |
| 2022 Q1 | -4.5 Million CAD | 17.3% |
| 2021 Q1 | -2.38 Million CAD | -28.07% |
| 2021 FY | -5.45 Million CAD | -192.24% |
| 2021 Q4 | -5.45 Million CAD | 17.88% |
| 2021 Q3 | -6.64 Million CAD | 6.18% |
| 2021 Q2 | -7.07 Million CAD | -196.16% |
| 2020 Q1 | 766.00 CAD | 0.0% |
| 2020 Q4 | -1.86 Million CAD | 0.0% |
| 2020 FY | -1.86 Million CAD | -243493.6% |
| 2019 FY | -766.00 CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 20.27 Million USD | 91.666% |
| Skye Bioscience, Inc. | -5.72 Million USD | 129.537% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 126.805% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 776.989% |
| Qrons Inc. | 351.42 Thousand USD | -380.868% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 8380.581% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 70.082% |
| BioStem Technologies, Inc. | 4.47 Million USD | 62.212% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -166.056% |
| CSL Limited | 10.52 Billion USD | 99.984% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 96.109% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 96.051% |
| Rebus Holdings, Inc. | 305 Thousand USD | -454.066% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 129100.076% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -171.529% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -8406.07% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 89.279% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 58.963% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -320.531% |
| SQZ Biotechnologies Company | -36.23 Million USD | 104.663% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 24.633% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -82.261% |
| Mesoblast Limited | 55.85 Million USD | 96.975% |
| Marizyme, Inc. | 18.56 Million USD | 90.899% |
| Genus plc | 190.6 Million USD | 99.113% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 24.417% |
| Pharming Group N.V. | 109.8 Million USD | 98.461% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -96.445% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -39.214% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -148.515% |
| ContraFect Corporation | -6.02 Million USD | 128.043% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -1155.135% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -46.257% |
| IMV Inc. | 7.67 Million USD | 77.969% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 69.285% |
| MultiCell Technologies, Inc. | 90.04 USD | -1876733.629% |
| ONE Bio Corp. | 9.04 Million USD | 81.306% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 330.239% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 86.947% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -23.533% |
| Q BioMed Inc. | 4.06 Million USD | 58.377% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 94.469% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -67.696% |
| Biomind Labs Inc. | 711.4 Thousand USD | -137.545% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 97.209% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 15.479% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 86.804% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -369.795% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -1108.764% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 23.255% |
| GB Sciences, Inc. | 1.74 Million USD | 3.286% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 1019.484% |
| HST Global, Inc. | 96.79 Thousand USD | -1645.892% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -719.477% |
| Halberd Corporation | 144.72 Thousand USD | -1067.696% |
| Enzolytics Inc. | 981.65 Thousand USD | -72.148% |
| Agentix Corp. | 37.63 Thousand USD | -4390.715% |
| Resverlogix Corp. | 6.45 Million USD | 73.804% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 351.067% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.083% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 103.595% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 76.101% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 37.61% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 119.117% |
| AVAX Technologies, Inc. | -5.9 Million USD | 128.627% |
| Zenith Capital Corp. | 10.06 Thousand USD | -16691.544% |
| Genscript Biotech Corporation | -1.06 Billion USD | 100.159% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -743.129% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 29.175% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -927.239% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 9325.358% |
| Kadimastem Ltd | -253.1 Thousand USD | 767.676% |
| Helix BioMedix, Inc. | -2.57 Million USD | 165.754% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -739.686% |
| LadRx Corporation | -2.03 Million USD | 182.982% |
| Cell Source, Inc. | 9.23 Million USD | 81.695% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -166.056% |
| NovAccess Global Inc. | 2.17 Million USD | 22.427% |
| Affymax, Inc. | -5.59 Million USD | 130.193% |
| Itoco Inc. | 228.3 Thousand USD | -640.194% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -1142.675% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 65.909% |
| Mobile Lads Corp. | 484.23 Thousand USD | -248.986% |
| CytoDyn Inc. | 20.26 Million USD | 91.66% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 261290.263% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 18333.049% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 78.07% |
| SYBLEU INC | 473.71 Thousand USD | -256.734% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 62.085% |
| International Stem Cell Corporation | 2.59 Million USD | 34.753% |
| Bioxytran, Inc. | 1.89 Million USD | 11.007% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -2607.611% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 22.514% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 50.789% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 80.242% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -118.727% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 235.192% |
| Neutra Corp. | 52.18 Thousand USD | -3138.165% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 167.895% |
| PureTech Health plc | -167.19 Million USD | 101.011% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 790.015% |
| IXICO plc | -4.44 Million USD | 138.022% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 87.216% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 96.919% |
| CSL Limited | 10.52 Billion USD | 99.984% |
| Cellectis S.A. | -43.81 Million USD | 103.857% |